1 out of 4 chosen companies

1 out of 4 chosen companies

CardioSecur accepted to the German Accelerator Life Sciences program

January 13th, 2016

 

CardioSecur has been selected to participate in the German Accelerator Life Sciences program in Cambridge. Out of 30 submitted applications, the German Accelerator has chosen 4 companies, including CardioSecur, for their support program.

 

As a broader part of a German government initiative, the German Accelerator Life Sciences supports high-tech innovation and life science entrepreneurship in Germany. “Our goal is to help build success stories that will motivate entrepreneurs, investors, and the general public to believe in Germany’s future as a global leader in medical innovation. We are excited to partner with these four cool companies with the potential to build flagships for the German life science ecosystem,” says Christoph Lengauer, CEO of GALS.

 

Back



Latest Articles

Woman using the mobile ECG CardioSecur at home.

The pandemic caused by the novel coronavirus COVID-19 is currently on the rise worldwide and the resulting crisis is also having a major impact on healthcare systems. Doctors1 and leading professional…

Patients with a history of cardiovascular disease may suffer from complications if they contract the new coronavirus SARS-CoV-2 (COVID-19). This may include plaque destabilization, infarction or exace…